SUJAY KANGO
CIK 1336503 · EVP, Chief Commercial Officer · last filed 2026-05-22
SUJAY KANGO is an EVP, Chief Commercial Officer who has filed 24 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for DNTH, was dated May 22, 2026. Across all open-market trades the lifetime net is −$3.7M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
24
-$3.74M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DNTH | Director | — | $82.07 | — | $0 | 2 | 2026-05-22 |
| Lite Strategy, Inc. (MEIP) Delisted | Director | — | $3.20 | — | $0 | 3 | 2023-10-12 |
| INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Chief Commercial Officer | 4,197 | $0.04 | $188 | -$95.9K | 5 | 2022-03-31 |
| ACCELERON PHARMA INC (XLRN) Delisted | EVP, Chief Commercial Officer | 0 | $178.75 | $0 | -$3.64M | 14 | 2021-11-22 |
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-22 | DNTH | Grant (A) | — | $0 | EDGAR |
| 2025-03-05 | DNTH | Grant (A) | — | $0 | EDGAR |
| 2023-10-12 | Lite Strategy, Inc. (MEIP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-07-07 | Lite Strategy, Inc. (MEIP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-31 | INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-11-23 | Lite Strategy, Inc. (MEIP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-11-22 | ACCELERON PHARMA INC (XLRN) Delisted | Mixed | −18,509 | $0 | EDGAR |
| 2021-09-27 | ACCELERON PHARMA INC (XLRN) Delisted | Mixed | — | -$672.0K | EDGAR |
| 2021-09-22 | ACCELERON PHARMA INC (XLRN) Delisted | Mixed | — | -$547.1K | EDGAR |
| 2021-06-08 | ACCELERON PHARMA INC (XLRN) Delisted | Tax (F) | −887 | -$116.1K | EDGAR |